ALLISON BROCHTRUP: Open Payments
NPI 1104405992 · BROOKFIELD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 34 payments from 10 companies in 2025. Trend: 2023 $375 · 2024 $800 · 2025 $701
Food & beverage: $681Education: $20
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 7 | $132 |
| Alnylam Pharmaceuticals Inc. | 5 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Novo Nordisk Inc | 3 | $70 |
| Abbott Laboratories | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: FFRct, ONPATTRO, Kerendia, Wegovy, CARDIOMEMS, ELIQUIS, LEQVIO, WAINUA.
Industry payments across WI — which companies pay providers there.
